Valve-in-Valve Transcatheter Aortic Valve Implantation With Acurate neo for a Degenerated bio-Bentall

Cardiovasc Revasc Med. 2020 Nov;21(11S):18-20. doi: 10.1016/j.carrev.2019.09.017. Epub 2019 Oct 23.

Abstract

A 79-year-old man with heart failure was referred to our attention for a degenerated bio-Bentall Mitroflow 27. The Heart Team decided for a valve-in-valve (ViV) transcatheter aortic valve implantation with an Acurate neo M associated to coronary protection due to high risk of coronary obstruction (CO). Besides the supra-anular design, this case shows additional potential advantages of the Acurate neo in ViV procedures: the upper crown, which is meant to favor supra-anular anchoring, also let to cap the bioprosthesis leaflets and minimize the risk of CO; there is not any interference between the valve cage and the stents protruding into the aorta, avoiding potential stent crushing and assuming an easier future coronary engagement.

Keywords: Coronary obstruction; Coronary protection; Transcatheter aortic valve implantation; Valve-in-valve.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aortic Valve / surgery
  • Aortic Valve Stenosis* / surgery
  • Bioprosthesis*
  • Heart Valve Prosthesis Implantation*
  • Heart Valve Prosthesis*
  • Humans
  • Male
  • Prosthesis Design
  • Prosthesis Failure
  • Transcatheter Aortic Valve Replacement*
  • Treatment Outcome